Phase II, randomized, multicentric study of docetaxel and zoledronic acid versus zoledronic acid in patient with prostate cancer and bone metastase treated with LHRH

Registry ID

EUCTR2008-002838-30

Source registry

EUCTR

Status

Prematurely Ended

Phase

PHASE2

Sponsor

ISTITUTO SCIENTIFICO ROMAGNOLO PER LO STUDIO E LA CURA DEI TUMORI

Start date

2008-08-22

Last update

2026-08-16

Conditions

• Advanced prostate cancer

Summary

Progression free survival

Locations

• , , Italy

View on source registry